1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS: DRUG DELIVERY MARKET
3.2. DEVELOPMENT OF DRUG DELIVERY SYSTEM
3.3. MARKET DEFINITION
3.4. KEY DRIVERS
3.4.1. GROWING PREVALENCE OF RESPIRATORY DISEASE
3.4.2. ADVANCEMENTS IN TECHNOLOGY
3.4.3. RISING GERIATRIC POPULATION
3.5. KEY RESTRAINTS
3.5.1. STRINGENT REGULATION AND PATENT EXPIRY
3.5.2. INCREASING DRUG RECALLS AND DRUG FAILURES
3.5.3. SIDE EFFECTS AND RISK ASSOCIATED WITH THE DRUGS

4. KEY ANALYTICS
4.1. PORTER'S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER'S POWER
4.1.4. SUPPLIER'S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. REGULATORY FRAMEWORK
4.3. IMPACT OF COVID-19 ON PULMONARY DRUG DELIVERY MARKET
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. KEY INVESTMENT INSIGHTS

5. MARKET BY APPLICATION
5.1. ASTHMA
5.2. CHRONIC OBSTRUCTIVE PULMONARY DISEASE
5.3. ALLERGIC RHINITIS
5.4. CYSTIC FIBROSIS
5.5. OTHER APPLICATIONS

6. MARKET BY DISTRIBUTION CHANNEL
6.1. HOSPITAL PHARMACIES
6.2. RETAIL PHARMACIES
6.3. E-COMMERCE

7. MARKET BY END-USER
7.1. HOSPITALS & CLINICS
7.2. HOMECARE

8. MARKET BY PRODUCT
8.1. METERED DOSE INHALERS
8.2. DRY POWDER INHALERS
8.3. NEBULIZER
8.3.1. PNEUMATIC NEBULIZER
8.3.1.1. BREATH ACTUATED PNEUMATIC NEBULIZER
8.3.1.2. VENTED PNEUMATIC NEBULIZER
8.3.2. MESH NEBULIZER
8.3.2.1. VIBRATING MESH NEBULIZER
8.3.2.2. STATIC MESH NEBULIZER
8.3.3. ULTRASONIC NEBULIZER
8.4. ACCESSORIES

9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. THE UNITED STATES
9.1.2. CANADA
9.2. EUROPE
9.2.1. GERMANY
9.2.2. THE UNITED KINGDOM
9.2.3. FRANCE
9.2.4. ITALY
9.2.5. RUSSIA
9.2.6. BELGIUM
9.2.7. POLAND
9.2.8. REST OF EUROPE
9.3. ASIA PACIFIC
9.3.1. CHINA
9.3.2. JAPAN
9.3.3. INDIA
9.3.4. AUSTRALIA & NEW ZEALAND
9.3.5. SOUTH KOREA
9.3.6. THAILAND
9.3.7. INDONESIA
9.3.8. VIETNAM
9.3.9. REST OF ASIA PACIFIC
9.4. REST OF WORLD
9.4.1. LATIN AMERICA
9.4.2. MIDDLE EAST & AFRICA

10. COMPANY PROFILES
10.1. 3M COMPANY
10.2. ACTELION PHARMACEUTICALS LTD
10.3. AEROGEN
10.4. AGILENT TECHNOLOGIES INC
10.5. ASTRAZENECA PLC
10.6. BOEHRINGER INGELHEIM GMBH
10.7. CLEMENT CLARKE INTERNATIONAL
10.8. GF HEALTH PRODUCTS INC
10.9. GLAXOSMITHKLINE PLC
10.10. KONINKLIJKE PHILIPS NV
10.11. MERCK & CO INC
10.12. NOVARTIS AG
10.13. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
10.14. VECTURA GROUP PLC